Study of a new injection for endometriosis pain
Part of Women’s health & pregnancy clinical trials.
This study tests a new medicine called HHK001 for endometriosis. It is compared with a standard treatment (Enantone) to see if it is safe and works well to reduce symptoms.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a woman aged 18 to 45.
- Your weight is at least 40 kg (about 88 pounds) and your body mass index is between 19 and 28.
- You have a confirmed diagnosis of endometriosis and your doctor says this type of medicine could help you.
- Your menstrual cycle is usually 21 to 35 days long.
- You are not planning to get pregnant, freeze eggs, or donate eggs, and you agree to use effective birth control during the study and for 3 months after the last dose.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests an investigational injectable medicine for endometriosis and compares it with an approved drug. It aims to see if the new medicine works as well and is safe. Women with endometriosis who are not planning to get pregnant may join.
This trial tests a drug called GnRH agonist to see if it helps people with endometriosis cysts. It might offer a new treatment option for those with this condition.
This trial studies whether giving a GnRH “downshifting” shot before transferring a frozen embryo can improve pregnancy outcomes for people with endometriosis or adenomyosis. It may help by changing hormone activity before the transfer.
This trial tests an experimental drug called HMI-115 to see if it reduces pain from endometriosis. If you have moderate to severe period pain and non-period pain, and you have a surgical diagnosis, you may be able to join.
This study tests whether a drug called relugolix CT can reduce pelvic pain from endometriosis. You'll have brain scans and pain tests to measure how your body processes pain. It might help if other treatments haven't worked well.
This trial tests whether taking a medication (Rel-CT) after surgery helps improve outcomes for people with endometriosis. It may reduce the chance of symptoms returning after the tissue is removed.
Hear when a new Endometriosis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.